Die Performance der Aurobindo Pharma liefert Statistiken zur Entwicklung des Aktienbarometers auf Monatsbasis. Die Wertentwicklung des Aurobindo Pharma (INE406A01037) wird für jeden einzelnen Monat unter Berücksichtigung jeglicher Performances berechnet.
Lfd. Jahr | 1 Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre | |
---|---|---|---|---|---|---|
Performance | +4,12 % | -0,19 % | +8,65 % | +16,96 % | +84,10 % | +48,72 % |
Hoch | 1.177,00 | 1.163,00 | 1.163,00 | 1.177,00 | 1.177,00 | 1.177,00 |
Tief | 959,05 | 1.066,05 | 959,05 | 942,00 | 581,50 | 281,15 |
Volatilität | - | +27,40 % | +28,79 % | +30,59 % | +29,27 % | +30,87 % |
Jahr | Jahresstart | Jahresende | % |
---|---|---|---|
2024 | 1.084,00 | - | +4,12 % |
2023 | 435,05 | 1.083,85 | +149,13 % |
2022 | 732,35 | 438,75 | -40,09 % |
2021 | 925,00 | 734,85 | -20,56 % |
2020 | 458,80 | 919,50 | +100,41 % |
2019 | 737,25 | 456,50 | -38,08 % |
2018 | 686,75 | 737,15 | +7,34 % |
2017 | 679,35 | 691,15 | +1,74 % |
2016 | 887,30 | 673,60 | -24,08 % |
2015 | 567,45 | 875,95 | +54,37 % |
2014 | 196,93 | 571,93 | +190,43 % |
2013 | 97,28 | 197,53 | +103,06 % |
2012 | 43,20 | 95,25 | +120,49 % |
2011 | 82,20 | 42,68 | -48,08 % |
1970 | 1.077,95 | 1.070,50 | -0,69 % |
2004 | nan | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2005 | nan | nan | ||||||||||||||||||
2006 | nan | nan | nan | |||||||||||||||||
2007 | nan | nan | nan | nan | ||||||||||||||||
2008 | nan | nan | nan | nan | nan | |||||||||||||||
2009 | nan | nan | nan | nan | nan | nan | ||||||||||||||
2010 | nan | nan | nan | nan | nan | nan | nan | |||||||||||||
2011 | inf | inf | inf | inf | inf | inf | inf | inf | ||||||||||||
2012 | inf | inf | inf | inf | inf | inf | inf | inf | 123.20 | |||||||||||
2013 | inf | inf | inf | inf | inf | inf | inf | inf | 115.14 | 107.38 | ||||||||||
2014 | inf | inf | inf | inf | inf | inf | inf | inf | 137.53 | 145.04 | 189.55 | |||||||||
2015 | inf | inf | inf | inf | inf | inf | inf | inf | 112.85 | 109.51 | 110.59 | 53.16 | ||||||||
2016 | inf | inf | inf | inf | inf | inf | inf | inf | 73.64 | 63.07 | 50.52 | 8.53 | -23.10 | |||||||
2017 | inf | inf | inf | inf | inf | inf | inf | inf | 59.06 | 48.64 | 36.77 | 6.52 | -11.17 | 2.61 | ||||||
2018 | inf | inf | inf | inf | inf | inf | inf | inf | 50.23 | 40.64 | 30.13 | 6.55 | -5.59 | 4.61 | 6.66 | |||||
2019 | inf | inf | inf | inf | inf | inf | inf | inf | 34.48 | 25.09 | 14.98 | -4.41 | -15.03 | -12.16 | -18.73 | -38.07 | ||||
2020 | inf | inf | inf | inf | inf | inf | inf | inf | 40.65 | 32.77 | 24.57 | 8.24 | 0.98 | 8.09 | 9.98 | 11.69 | 101.42 | |||
2021 | inf | inf | inf | inf | inf | inf | inf | inf | 32.92 | 25.49 | 17.85 | 3.65 | -2.88 | 1.76 | 1.54 | -0.10 | 26.88 | -20.08 | ||
2022 | inf | inf | inf | inf | inf | inf | inf | inf | 23.60 | 16.50 | 9.27 | -3.26 | -9.40 | -6.90 | -8.69 | -12.17 | -1.31 | -30.92 | -40.29 | |
2023 | inf | inf | inf | inf | inf | inf | inf | inf | 30.94 | 24.74 | 18.56 | 7.36 | 2.70 | 7.03 | 7.79 | 8.01 | 24.13 | 5.63 | 21.45 | 147.03 |
Ø | nan | nan | nan | nan | nan | nan | nan | inf | 69.52 | 58.08 | 50.28 | 9.59 | -7.94 | 0.72 | -0.24 | -6.13 | 37.78 | -15.12 | -9.42 | 147.03 |
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
> +50% | 2023, 2020, 2015, 2014, 2013, 2012 |
+50% | Kein Jahr mit entsprechender Performance |
+40% | Kein Jahr mit entsprechender Performance |
+30% | Kein Jahr mit entsprechender Performance |
+20% | Kein Jahr mit entsprechender Performance |
+10% | 2018, 2017 |
-10% | 1970 |
-20% | Kein Jahr mit entsprechender Performance |
-30% | 2021, 2016 |
-40% | 2019 |
-50% | 2022, 2011 |
< -50% | Kein Jahr mit entsprechender Performance |
-50% | +50% | ||
-40% | +40% | ||
-30% | +30% | ||
-20% | +20% | ||
-10% | +10% | ||
-0% | +0% |